Women's Health

Help Shape the Future of Denosumab Treatment

As biosimilars enter the denosumab landscape, your perspective as a healthcare provider is critical in understanding what factors influence treatment decisions. This brief survey explores your views on reimbursement considerations, coding challenges, switching comfort, and drivers of biosimilar choice. As a thank you, by completing the survey, you’ll be entered into a drawing for a chance to win a $200 gift card.

Take the survey now and make your voice heard

Latest News

Racial Disparity Found in Menopausal Hormone Therapy Prescribing: Daily Dose / Image credit: ©New Africa/AdobeStock
Racial Disparity Found in Menopausal Hormone Therapy Prescribing: Daily Dose

December 16th 2025

Your daily dose of the clinical news you may have missed.

Weekly Dose Podcast: New AD Blood Test, Elinzanetant’s Sleep Effects, Lung Cancer Screening Success, Menopause Symptom Burden, and VMS Treatment Approval
Weekly Dose Podcast: New AD Blood Test, Elinzanetant’s Sleep Effects, Lung Cancer Screening Success, Menopause Symptom Burden, and VMS Treatment Approval

December 10th 2025

Perimenopause Misdiagnosis Remains Widespread as Clinicians Miss Hormonal Transition Explains Bruce Dorr, MD, URPS, IFM-CP
Perimenopause Misdiagnosis Remains Widespread as Clinicians Miss Hormonal Transition Explains Bruce Dorr, MD, URPS, IFM-CP

December 9th 2025

Elinzanetant Provides VMS-Independent Sleep Improvement in Postmenopausal Women: Daily Dose / Image credit: ©New Africa/AdobeStock
Elinzanetant Provides VMS-Independent Sleep Improvement in Postmenopausal Women: Daily Dose

December 3rd 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.